Substituted quinoxalines as FGFR kinase inhibitors
US-9290478-B2 · Mar 22, 2016 · US
This page is not indexed by search engines while we improve data quality.
Ligny Yannick Aime Eddy — Human Necessities
Ligny Yannick Aime Eddy holds 1 patent in Human Necessities, with representative filings summarized below.
| Metric | Value |
|---|---|
| Company | Ligny Yannick Aime Eddy |
| Technology | Human Necessities |
| Patents in slice | 1 |
| Recent patents in slice | 0 |
| First year | 2016 |
| Last year | 2016 |
Representative patents
Notable publications linking Ligny Yannick Aime Eddy to Human Necessities.
Substituted quinoxalines as FGFR kinase inhibitors
US-9290478-B2 · Mar 22, 2016 · US
Substituted quinoxalines as FGFR kinase inhibitors
US-9290478-B2 · Mar 22, 2016 · US
Substituted quinoxalines as FGFR kinase inhibitors
US-9290478-B2 · Mar 22, 2016 · US
Recent filings
Latest patents from Ligny Yannick Aime Eddy in Human Necessities.
Substituted quinoxalines as FGFR kinase inhibitors
US-9290478-B2 · Mar 22, 2016 · US
Substituted quinoxalines as FGFR kinase inhibitors
US-9290478-B2 · Mar 22, 2016 · US
Substituted quinoxalines as FGFR kinase inhibitors
US-9290478-B2 · Mar 22, 2016 · US
Substituted quinoxalines as FGFR kinase inhibitors
US-9290478-B2 · Mar 22, 2016 · US
Related pages
Navigate to parent entity pages.